Neoleukin Therapeutics, Inc. (NLTX)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
03-May-22 7:16 PM
View: 
Patel Priti
Chief Medical Officer
Neoleukin Therapeutics, Inc. (NLTX) 02-May-22Option Sale 5,538$1.22$6,748.61(46%)
12.0K to 6.46K
03-May-22 7:16 PM
View: 
Patel Priti
Chief Medical Officer
Neoleukin Therapeutics, Inc. (NLTX) 30-Apr-22Option Exercise 10,000----500%
2.0K to 12.0K
14-Feb-22 10:00 PM
View: 
Drachman Jonathan G
President and CEO
Director
Neoleukin Therapeutics, Inc. (NLTX) 26-Oct-21Gift 150,000----(6%)
2.55M to 2.4M
14-Feb-22 10:00 PM
View: 
Drachman Jonathan G
President and CEO
Director
Neoleukin Therapeutics, Inc. (NLTX) 26-Oct-21Gift 150,000----6%
2.4M to 2.55M
26-Aug-21 7:08 PM
View: 
Drachman Jonathan G
President and CEO
Director
Neoleukin Therapeutics, Inc. (NLTX) 25-Aug-21Market Purchase 50,000$6.45$322,450.002%
2.35M to 2.4M
26-Aug-21 7:08 PM
View: 
Drachman Jonathan G
President and CEO
Director
Neoleukin Therapeutics, Inc. (NLTX) 24-Aug-21Market Purchase 100,000$6.11$611,100.004%
2.25M to 2.35M
17-Jun-21 9:46 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 16-Jun-21Market Sale (Planned) 600$10.19$6,114.00(< 1%)
1.35M to 1.35M
1%
11-Jun-21 4:13 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 09-Jun-21Market Sale (Planned) 650$10.82$7,035.99(< 1%)
1.35M to 1.35M
2%
09-Jun-21 5:22 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 08-Jun-21Market Sale (Planned) 600$11.00$6,600.00(< 1%)
1.35M to 1.35M
07-Jun-21 5:07 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 04-Jun-21Market Sale (Planned) 600$10.00$6,000.00(< 1%)
1.35M to 1.35M
3%
07-Jun-21 5:06 PM
View: 
Drachman Jonathan G
President and CEO
Director
Neoleukin Therapeutics, Inc. (NLTX) 04-Jun-21Market Purchase 10,000$9.61$96,082.00< 1%
2.24M to 2.25M
< 1%
07-Jun-21 5:06 PM
View: 
Drachman Jonathan G
President and CEO
Director
Neoleukin Therapeutics, Inc. (NLTX) 03-Jun-21Market Purchase 40,000$9.48$379,272.002%
2.2M to 2.24M
2%
26-May-21 7:37 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 26-May-21Market Sale (Planned) 600$10.00$6,000.00(< 1%)
1.36M to 1.35M
1%
21-May-21 5:24 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 19-May-21Market Sale (Planned) 600$10.63$6,378.00(< 1%)
1.36M to 1.36M
2%
12-May-21 8:53 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 12-May-21Market Sale (Planned) 1,200$11.09$13,308.00(< 1%)
1.36M to 1.35M
(3%)
06-May-21 5:28 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 05-May-21Market Sale (Planned) 1,200$11.30$13,560.00(< 1%)
1.36M to 1.36M
(11%)
30-Apr-21 5:52 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 28-Apr-21Market Sale (Planned) 2,400$12.58$30,192.00(< 1%)
1.36M to 1.36M
(3%)
27-Apr-21 7:59 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 26-Apr-21Market Sale (Planned) 600$13.00$7,800.00(< 1%)
1.36M to 1.36M
(< 1%)
22-Apr-21 5:11 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 21-Apr-21Market Sale (Planned) 1,800$11.98$21,564.00(< 1%)
1.36M to 1.36M
(3%)
16-Apr-21 10:00 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 14-Apr-21Market Sale (Planned) 1,800$12.22$21,996.00(< 1%)
1.36M to 1.36M
< 1%
08-Apr-21 7:06 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 07-Apr-21Market Sale (Planned) 1,800$12.02$21,636.00(< 1%)
1.37M to 1.36M
(1%)
06-Apr-21 8:37 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 05-Apr-21Market Sale (Planned) 600$13.00$7,800.00(< 1%)
1.37M to 1.37M
(< 1%)
02-Apr-21 5:21 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 31-Mar-21Market Sale (Planned) 1,800$11.96$21,528.00(< 1%)
1.37M to 1.37M
2%
24-Mar-21 6:48 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 24-Mar-21Market Sale (Planned) 1,800$11.95$21,515.90(< 1%)
1.37M to 1.37M
< 1%
24-Mar-21 6:48 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 22-Mar-21Market Sale (Planned) 600$12.00$7,200.00(< 1%)
1.37M to 1.37M
< 1%
18-Mar-21 8:45 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 17-Mar-21Market Sale (Planned) 1,200$11.36$13,632.00(< 1%)
1.37M to 1.37M
< 1%
18-Mar-21 8:44 PM
View: 
Ho Robert
Chief Financial Officer
Neoleukin Therapeutics, Inc. (NLTX) 17-Mar-21Market Option Sale 6,497$11.01$71,556.00(23%)
28.0K to 21.5K
18-Mar-21 8:44 PM
View: 
Ho Robert
Chief Financial Officer
Neoleukin Therapeutics, Inc. (NLTX) 16-Mar-21Option Exercise 25,000----833%
3.0K to 28.0K
11-Mar-21 4:14 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 10-Mar-21Market Sale (Planned) 1,800$11.97$21,540.10(< 1%)
1.37M to 1.37M
2%
04-Mar-21 6:52 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 03-Mar-21Market Sale (Planned) 1,800$11.87$21,360.10(< 1%)
1.38M to 1.37M
(1%)
25-Feb-21 8:17 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 25-Feb-21Market Sale (Planned) 600$13.00$7,800.00(< 1%)
1.38M to 1.38M
4%
25-Feb-21 8:17 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 24-Feb-21Market Sale (Planned) 1,800$12.14$21,852.00(< 1%)
1.38M to 1.38M
(2%)
18-Feb-21 4:20 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 17-Feb-21Market Sale (Planned) 2,400$12.70$30,480.00(< 1%)
1.38M to 1.38M
2%
12-Feb-21 4:23 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 10-Feb-21Market Sale (Planned) 3,000$14.20$42,600.00(< 1%)
1.38M to 1.38M
12%
09-Feb-21 4:41 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 05-Feb-21Market Sale (Planned) 600$14.00$8,400.00(< 1%)
1.38M to 1.38M
11%
05-Feb-21 4:51 PM
View: 
Walkey Carl
Senior Vice President
Neoleukin Therapeutics, Inc. (NLTX) 03-Feb-21Market Sale (Planned) 2,400$13.23$31,752.00(< 1%)
1.39M to 1.38M
6%
23-Dec-20 7:31 PM
View: 
Baker Bros Advisors LLC
Director
Neoleukin Therapeutics, Inc. (NLTX) 07-Jul-20Market Purchase 424,000$15.25$6,466,000.0012%
3.4M to 3.83M
(18%)
06-Apr-20 7:04 PM
View: 
Redmile Group, LLC
10% Owner
Neoleukin Therapeutics, Inc. (NLTX) 02-Apr-20Market Sale 9,834$11.31$111,214.00(< 1%)
4.05M to 4.04M
(10%)
06-Apr-20 7:04 PM
View: 
Redmile Group, LLC
10% Owner
Neoleukin Therapeutics, Inc. (NLTX) 02-Apr-20Market Purchase 39,300$11.37$446,958.00< 1%
4.01M to 4.05M
9%
06-Apr-20 7:04 PM
View: 
Redmile Group, LLC
10% Owner
Neoleukin Therapeutics, Inc. (NLTX) 01-Apr-20Market Purchase 42,500$11.10$471,630.001%
3.98M to 4.02M
12%
06-Apr-20 7:04 PM
View: 
Redmile Group, LLC
10% Owner
Neoleukin Therapeutics, Inc. (NLTX) 01-Apr-20Market Sale 9,834$11.08$108,940.00(< 1%)
4.02M to 4.01M
(12%)
06-Apr-20 7:04 PM
View: 
Redmile Group, LLC
10% Owner
Neoleukin Therapeutics, Inc. (NLTX) 31-Mar-20Market Purchase 30,000$10.31$309,388.00< 1%
3.95M to 3.98M
21%
06-Apr-20 7:04 PM
View: 
Redmile Group, LLC
10% Owner
Neoleukin Therapeutics, Inc. (NLTX) 30-Mar-20Market Purchase 32,500$9.94$322,910.00< 1%
3.92M to 3.95M
25%
06-Apr-20 7:04 PM
View: 
Redmile Group, LLC
10% Owner
Neoleukin Therapeutics, Inc. (NLTX) 27-Mar-20Market Purchase 50,000$9.21$460,395.001%
3.87M to 3.92M
35%
20-Dec-19 5:16 PM
View: 
Baker Bros Advisors LLC
Director
Neoleukin Therapeutics, Inc. (NLTX) 20-Dec-19Disposition 10,925,500----(38%)
28.65M to 17.73M
20-Dec-19 5:16 PM
View: 
Baker Bros Advisors LLC
Director
Neoleukin Therapeutics, Inc. (NLTX) 20-Dec-19Private Purchase 3,017,540$8.40$25,347,400.0012%
25.63M to 28.65M
20-Dec-19 6:53 PM
View: 
Drachman Jonathan G
President and CEO
Director
Neoleukin Therapeutics, Inc. (NLTX) 20-Dec-19Private Purchase 119,047$8.40$999,995.006%
2.08M to 2.2M
20-Dec-19 6:53 PM
View: 
Drachman Jonathan G
President and CEO
Director
Neoleukin Therapeutics, Inc. (NLTX) 12-Nov-19Conversion 1,261,600----152%
830.66K to 2.09M
20-Dec-19 6:53 PM
View: 
Drachman Jonathan G
President and CEO
Director
Neoleukin Therapeutics, Inc. (NLTX) 12-Nov-19Conversion 12,616----(< 1%)
2.09M to 2.08M
11-Sep-19 5:39 PM
View: 
Drachman Jonathan G
See Remarks
Director
Neoleukin Therapeutics, Inc. (NLTX) 11-Sep-19Market Purchase 136,436$3.30$449,898.0030%
455.42K to 591.86K
278%